Who is sponsoring NCT06083428?

NCT06083428 is sponsored by Poznan University of Medical Sciences.

What drugs are being tested in NCT06083428?

Interventions in NCT06083428: Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block, Ropivacaine 0.2% Injectable Solution - PENG block, Control Test.

What condition does NCT06083428 study?

NCT06083428 studies Hip Arthropathy, Hip Osteoarthritis, Hip Pain Chronic.

Is NCT06083428 still recruiting?

NCT06083428 is currently completed. Last updated 18 June 2024.

Last reviewed 2024-06-18 · How we verify

NCT06083428

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Erector Spinae vs. PENG Block for Total Hip Arthroplasty

Completed Phase 4 Last updated 18 June 2024

What this trial tests

Phase 4 trial testing Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block in Hip Arthropathy in 90 participants. Completed in 11 June 2024.

Timeline

17 October 2023

Primary endpoint
11 June 2024

11 June 2024

Quick facts

Lead sponsor	Poznan University of Medical Sciences
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	90
Start date	17 October 2023
Primary completion	11 June 2024
Estimated completion	11 June 2024
Sites	1 location across Poland

Drugs / interventions tested

Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block — full drug profile →
Ropivacaine 0.2% Injectable Solution - PENG block — full drug profile →
Control Test — full drug profile →

Conditions studied

Hip Arthropathy — all drugs for Hip Arthropathy →
Hip Osteoarthritis — all drugs for Hip Osteoarthritis →
Hip Pain Chronic — all drugs for Hip Pain Chronic →

Sponsor

Poznan University of Medical Sciences

Who can join

Adults 20 to 90, any sex, with Hip Arthropathy or Hip Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effect of PENG block and ESPB on pain management, and NLR and PLR following knee arthroplasty

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Erector spinae plane block (ESPB) vs. pericapsular nerve group (PENG) block in total hip arthroplasty in elderly patients: a randomized, double-blinded, controlled trial.
Reysner T, Kowalski G, Reysner M, Lapaj L, et al · · 2025 · cited 3× · PMID 40420611 · DOI 10.5114/ait/203170

Verify or expand the search:

Other recruiting trials for Hip Arthropathy

Currently open trials in the same condition.

NCT07023094 — PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery · Phase 4 · recruiting
NCT06017128 — Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study · NA · active not recruiting
NCT06603831 — Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology · NA · recruiting
NCT06317870 — Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty · NA · recruiting
NCT06432543 — Polyethylene Wear Particle Analysis of THA · recruiting

Other Poznan University of Medical Sciences trials

Trials by the same sponsor.

NCT07449468 — PENG Block and Delirium After Hip Arthroplasty · NA · not yet recruiting
NCT07449442 — SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty · NA · not yet recruiting
NCT07474896 — Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery · NA · not yet recruiting
NCT07474909 — Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery · NA · not yet recruiting
NCT07449403 — SII Levels Following PENG Block in Hip Arthroplasty · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06083428 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Poznan University of Medical Sciences
Last refreshed: 18 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06083428.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing